IVD News and Research

RSS
Quanterix’s Simoa® technology drives advances in Alzheimer’s disease research presented at 2022 Clinical Trials On Alzheimer’s Disease (CTAD) conference

Quanterix’s Simoa® technology drives advances in Alzheimer’s disease research presented at 2022 Clinical Trials On Alzheimer’s Disease (CTAD) conference

Logical Biological exhibit at MEDICA

Logical Biological exhibit at MEDICA

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

New evaluation data shows the clinical utility of SOPHiA DDM Dx HRD Solution

New evaluation data shows the clinical utility of SOPHiA DDM Dx HRD Solution

EKF introduces hand-held hemoglobin analyzer with secure POC connectivity

EKF introduces hand-held hemoglobin analyzer with secure POC connectivity

PerkinElmer’s Oxford Immunotec receives U.S. FDA approval for T-cell select to automate clinically superior tuberculosis detection

PerkinElmer’s Oxford Immunotec receives U.S. FDA approval for T-cell select to automate clinically superior tuberculosis detection

Yourgene Health Receives HSA approval for IONA Nx NIPT Workflow in Singapore

Yourgene Health Receives HSA approval for IONA Nx NIPT Workflow in Singapore

Re-defining the limits of single batch assay stabilisation

Re-defining the limits of single batch assay stabilisation

Rapidly growing nanotechnology firm launches new identity as MIP Discovery

Rapidly growing nanotechnology firm launches new identity as MIP Discovery

Saving lives with living cells: Beckman Coulter Life Sciences launches AQUIOS STEM System to provide a new solution for stem cell analysis

Saving lives with living cells: Beckman Coulter Life Sciences launches AQUIOS STEM System to provide a new solution for stem cell analysis

Study explores SARS-CoV-2 viremia kinetics

Study explores SARS-CoV-2 viremia kinetics

The Nucleic Acid Experts – Certified Twice!

The Nucleic Acid Experts – Certified Twice!

MIP Diagnostics secures £7.3M investment following achievement of critical milestones

MIP Diagnostics secures £7.3M investment following achievement of critical milestones

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

Study explores the gut microbiome of COVID-19 patients

Study explores the gut microbiome of COVID-19 patients

Expanded range of nucleic acid extraction kits for pathogens detection

Expanded range of nucleic acid extraction kits for pathogens detection

Study uses Promega LMR MSI Analysis System to detect microsatellite instability in multiple cancers

Study uses Promega LMR MSI Analysis System to detect microsatellite instability in multiple cancers

Synthetic antibody demonstrates Omicron detection along with all other variants of concern

Synthetic antibody demonstrates Omicron detection along with all other variants of concern

Very high rates of asymptomatic infection with Omicron compared to prior SARS-CoV-2 variants

Very high rates of asymptomatic infection with Omicron compared to prior SARS-CoV-2 variants

How the new In-Vitro Diagnostics Regulations are affecting the life sciences landscape

How the new In-Vitro Diagnostics Regulations are affecting the life sciences landscape